SimuTech Group Engineers Co-Author Chapter in Open-Access Medical Device VVUQ Handbook
The multi-author book was funded by Ansys — part of Synopsys — and Johnson & Johnson. The authors will present key applications during a webinar on September 10. ROCHESTER, N.Y., Aug. 26, 2026 /PRNewswire/ -- SimuTech Group announces the publication of a new chapter co-authored by two of...
Covered in this story
What has happened since
- Johnson & Johnson is down 3.9% since this was published, 55 days ago.
- Synopsys is up 9.2% since this was published, 55 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Johnson & Johnson
- Bernstein: $253 → $270 by Oct 2027 · Market Perform via Investing.com
- RBC Capital Markets: $249 → $280 by Oct 2027 · Outperform via GuruFocus
- RBC Capital Markets: $255 → $290 by Oct 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $JNJ yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Johnson & Johnson →Dalsna Finance is currently tracking 45 stories mentioning Johnson & Johnson, the earliest published 26 Aug 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.